Dipender Gill

Preventive Cardiology

Novo Nordisk (Denmark)

About

Dipender Gill works in Preventive Cardiology affiliated with Novo Nordisk (Denmark).

Dr. Dipender Gill is the CEO and Founder of Sequoia Genetics in the United States. He is also a clinician scientist affiliated with Imperial College London and specializes in General Internal Medicine and Clinical Pharmacology. He previously worked at Novo Nordisk in Denmark, focusing on human genetic data for drug development.

Research focus

Mendelian randomization for cardiovascular risksGenetic epidemiology of cardiometabolic diseasesInflammation and metabolic factors in heart diseaseDiabetes and lipoprotein effects on cardiovascular healthLifestyle and genetic influences on cardiac outcomes

Impact

500 pubs · 16,250 cites · h-index 61

Training

BMBCh
University of Oxford
2011
BA
University of Oxford
2008
PhD in Genetic Epidemiology
Imperial College London
2018

Affiliations

Work Experience

CEO and Founder

Sequoia Genetics · 2023 - Present

Clinician Scientist

Imperial College London · 2011 - Present

Researcher in Research and Early Development

Novo Nordisk · 2020 - 2023

Physician

National Health Service · 2011 - Present

Publications